Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- Parkinsons Disease Drugs Market Insight, Aspects, Review, and Survey Reports 2025on January 18, 2021 at 9:39 pm
The Global Parkinsons Disease Drugs Market Research Report Forecast 2020 – 2025 offers a comprehensive analysis ...
- Walney man praises his wife as his 'God send' for helping him through Parkinsonson January 9, 2021 at 4:24 am
A LOVING wife whose care has ‘saved the life’ of her husband after his Parkinson diagnosis has earned her praise.
- Rev. Karen Margaret Pearce (Hill)on January 7, 2021 at 4:29 pm
October 25, 1942 - January 5, 2021. Age 78, passed away in Dartmouth after a lengthy battle with Parkinsons Disease. She was born in Dartmouth to Guy and Jean (Meagher) Hill. Karen graduated the ...
- Otis "Nick" McGrawon December 30, 2020 at 3:13 am
At the age of 80, Nick McGraw passed away on Sunday December 13th at home after a 40-year battle with Parkinsons disease. He was born April 22, 1940, in North Carolina. After high school and tech ...
- Lilly Lays Out 2021 Expectations, Gene Therapy Acquisitionon December 15, 2020 at 7:25 am
Shares of Eli Lilly jumped Tuesday after the drugmaker laid out a better-than-expected revenue forecast and plans to buy a young company developing a potential Parkinsons disease treatment.
- Bringing history to the Parkinsonson September 27, 2020 at 1:48 pm
However, she did recognise some of the other's shown, including William's father. So I'm glad to have been able to bring back a little bit of family history to the Parkinsons.
- GMCL: Parkinsons really make their mark in Egerton winon September 9, 2020 at 9:17 am
EGERTON chased down a target of 173 to beat Royton, with Parkinsons at the forefront of their victory. Visitors Royton were limited to an all-out total of 172, with Matt Parkinson collecting 6-32 ...
- Parkinsons’ pills were top of the global popson April 24, 2020 at 11:54 am
PARKINSONS’ pills, manufactured in Burnley, were once known throughout the land – and even overseas. The company claimed that it sold more pills than any other business in the world ...
- Global Parkinsons Disease Drugs Market Statistics, Facts and Figures, Size, Share, Trends and Forecast 2020-2025on December 23, 2019 at 2:52 am
Global Parkinsons Disease Drugs Market Overview: The global Parkinsons Disease Drugs market is expected to grow at a significant pace, reports QY Research. Its latest research report, titled ...
via Bing News